Your browser doesn't support javascript.
loading
High-throughput, sliding-window algorithm for assessing chemical complementarity between immune receptor CDR3 domains and cancer mutant peptides: TRG-PIK3CA interactions and breast cancer.
Chobrutskiy, Boris I; Chobrutskiy, Andrea; Zaman, Saif; Yeagley, Michelle; Huda, Taha I; Blanck, George.
Afiliación
  • Chobrutskiy BI; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, FL, United States.
  • Chobrutskiy A; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, FL, United States.
  • Zaman S; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, FL, United States.
  • Yeagley M; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, FL, United States.
  • Huda TI; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, FL, United States.
  • Blanck G; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, FL, United States; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, United States. Electronic address: gblanck@usf.edu.
Mol Immunol ; 135: 247-253, 2021 07.
Article en En | MEDLINE | ID: mdl-33933816
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptores de Antígenos de Linfocitos T gamma-delta / Regiones Determinantes de Complementariedad / Fosfatidilinositol 3-Quinasa Clase I / Dominios Proteicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Mol Immunol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptores de Antígenos de Linfocitos T gamma-delta / Regiones Determinantes de Complementariedad / Fosfatidilinositol 3-Quinasa Clase I / Dominios Proteicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Mol Immunol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos